These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 5023231

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidus.
    Radó JP, Marosi J, Szende L, Takó J.
    Endokrinologie; 1973 Dec; 62(3):297-309. PubMed ID: 4790811
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chlorpropamide in diabetes insipidus in childhood.
    Rosenbloom AL.
    Curr Ther Res Clin Exp; 1971 Nov; 13(11):671-9. PubMed ID: 5000713
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacologic antidiuresis in diabetes insipidus. I. Chlorpropamide].
    Cabezas Cerrato J, Jiménez de Diego L, Fernández-Cruz A.
    Rev Clin Esp; 1970 Feb 15; 116(3):229-36. PubMed ID: 5426160
    [No Abstract] [Full Text] [Related]

  • 8. [Combined clofibrate-chlorpropamide therapy in diabetes insipidus complicated with diabetes mellitus].
    Czakó L, László FA, Kahán-László I.
    Endokrinologie; 1975 Aug 15; 65(3):364-74. PubMed ID: 1236680
    [Abstract] [Full Text] [Related]

  • 9. [Attempt at treatment of postvaccinal diabetes insipidus with chlorpropamide].
    Schneider D, Fleischmann J.
    Z Gesamte Inn Med; 1970 Aug 15; 25(16):774-9. PubMed ID: 5522137
    [No Abstract] [Full Text] [Related]

  • 10. [Chlorpropamide in diabetes insipidus].
    Uhlich E, Loeschke K.
    Minerva Med; 1973 May 05; 64(31):1702-4. PubMed ID: 4351789
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Experiences with chlorpropamide therapy of hypophyseal-hypothalamic diabetes insipidus].
    Monnens L, Neerincx R.
    Maandschr Kindergeneeskd; 1970 Jun 05; 38(4):93-106. PubMed ID: 5448975
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Use of chlorpropamide in diabetes insipidus of pituitary-hypothalamic origin].
    Artese R, Molocznik I, Guitelman A, Dickmann GH, Martinez Montes H, Pardal C.
    Prensa Med Argent; 1970 Jul 17; 57(20):971-5. PubMed ID: 5471513
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chlorpropamide treatment in diabetes insipidus.
    Meinders AE, Touber JL, de Vries LA.
    Lancet; 1967 Sep 09; 2(7515):544-6. PubMed ID: 4166898
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for permanent enhancement of residual ADH induced by antidiuretic agents (chlorpropamide, carbamazepine, clofibrate) in patients with pituitary diabetes insipidus.
    Radó JP.
    Endokrinologie; 1975 Jan 09; 64(2):217-22. PubMed ID: 1149696
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of diabetes insipidus by chlorpropamide].
    Bricaire H, Saltiel H, Schaison G, Valcke JC.
    Ann Endocrinol (Paris); 1969 Jan 09; 30(1):61-70. PubMed ID: 5774461
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.